Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01880814 · ClinicalTrials.gov registry record · NA
Using SMART Experimental Design to Personalize Treatment for Child Depression
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 44
- Enrollment target
NCT01880814: Completed NA study, sponsored by Massachusetts General Hospital.
NCT01880814 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 44 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01880814, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
Study Summary
The purpose of the study is: 1. To conduct a pilot SMART (Sequential, Multiple Assignment, Randomized) study with the long-term goal of developing a personalized treatment for child depression. 2. To collect pilot data on ways to personalize treatment for child depression using cognitive behavioral therapy (CBT), caregiver-child treatment, or both.
Interventions
- BEHAVIORAL Cognitive Behavioral Therapy (CBT)
- BEHAVIORAL Caregiver-Child Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2013-06 |
| Est. Completion | 2018-11-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01880814
The ClinicalTrials.gov registry entry for NCT01880814 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cognitive Behavioral Therapy (CBT) is the first listed.
NCT01880814 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01880814 about?
NCT01880814 is a clinical study titled "Using SMART Experimental Design to Personalize Treatment for Child Depression". The purpose of the study is: 1. To conduct a pilot SMART (Sequential, Multiple Assignment, Randomized) study with the long-term goal of developing a personalized treatment for child depression. 2. To collect pilot data on ways to personalize treatment for child depression using cognitive behavioral...
What is the current status of trial NCT01880814?
This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2013-06. Estimated completion is 2018-11-30.
What interventions are being tested in trial NCT01880814?
The interventions under investigation include: Cognitive Behavioral Therapy (CBT) (BEHAVIORAL), Caregiver-Child Treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT01880814?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.